CABOT CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CABOT CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $3.71B | Nov 24, 2025 |
| FY2025 | Sep 30, 2024 | $3.99B | Nov 24, 2025 |
| FY2025 | Sep 30, 2023 | $3.93B | Nov 24, 2025 |
| FY2024 | Sep 30, 2022 | $4.32B | Nov 20, 2024 |
| FY2023 | Sep 30, 2021 | $3.41B | Nov 22, 2023 |
| FY2020 | Sep 30, 2020 | $659.00M | Nov 25, 2020 |
| FY2020 | Jun 30, 2020 | $518.00M | Nov 25, 2020 |
| FY2020 | Mar 31, 2020 | $710.00M | Nov 25, 2020 |
| FY2020 | Dec 31, 2019 | $727.00M | Nov 25, 2020 |
| FY2020 | Sep 30, 2019 | $827.00M | Nov 25, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Sep 30, 2014 | $911.00M | Nov 26, 2014 |
| FY2014 | Jun 30, 2014 | $940.00M | Nov 26, 2014 |
| FY2014 | Mar 31, 2014 | $898.00M | Nov 26, 2014 |
| FY2014 | Dec 31, 2013 | $898.00M | Nov 26, 2014 |
| FY2013 | Sep 30, 2013 | $898.00M | Nov 27, 2013 |
| FY2013 | Jun 30, 2013 | $903.00M | Nov 27, 2013 |
| FY2013 | Mar 31, 2013 | $842.00M | Nov 27, 2013 |
| FY2013 | Dec 31, 2012 | $820.00M | Nov 27, 2013 |
| FY2012 | Sep 30, 2012 | $848.00M | Nov 29, 2012 |
| FY2012 | Jun 30, 2012 | $846.00M | Nov 29, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $940.00M | Nov 24, 2025 |
| FY2025 | Sep 30, 2024 | $960.00M | Nov 24, 2025 |
| FY2025 | Sep 30, 2023 | $839.00M | Nov 24, 2025 |
| FY2024 | Sep 30, 2022 | $885.00M | Nov 20, 2024 |
| FY2023 | Sep 30, 2021 | $799.00M | Nov 22, 2023 |
| FY2020 | Sep 30, 2020 | $137.00M | Nov 25, 2020 |
| FY2020 | Jun 30, 2020 | $69.00M | Nov 25, 2020 |
| FY2020 | Mar 31, 2020 | $153.00M | Nov 25, 2020 |
| FY2020 | Dec 31, 2019 | $141.00M | Nov 25, 2020 |
| FY2020 | Sep 30, 2019 | $171.00M | Nov 25, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $331.00M | Nov 24, 2025 |
| FY2025 | Sep 30, 2024 | $380.00M | Nov 24, 2025 |
| FY2025 | Sep 30, 2023 | $445.00M | Nov 24, 2025 |
| FY2024 | Sep 30, 2022 | $209.00M | Nov 20, 2024 |
| FY2023 | Sep 30, 2021 | $250.00M | Nov 22, 2023 |
| FY2020 | Sep 30, 2020 | ($272.00M) | Nov 25, 2020 |
| FY2020 | Jun 30, 2020 | ($6.00M) | Nov 25, 2020 |
| FY2020 | Mar 31, 2020 | ($1.00M) | Nov 25, 2020 |
| FY2020 | Dec 31, 2019 | $41.00M | Nov 25, 2020 |
| FY2020 | Sep 30, 2019 | $33.00M | Nov 25, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $621.00M | Nov 24, 2025 |
| FY2025 | Sep 30, 2024 | $614.00M | Nov 24, 2025 |
| FY2025 | Sep 30, 2023 | $526.00M | Nov 24, 2025 |
| FY2024 | Sep 30, 2022 | $389.00M | Nov 20, 2024 |
| FY2023 | Sep 30, 2021 | $454.00M | Nov 22, 2023 |
| FY2022 | Sep 30, 2020 | $21.00M | Nov 23, 2022 |
| FY2021 | Sep 30, 2019 | $306.00M | Nov 29, 2021 |
| FY2020 | Sep 30, 2018 | $144.00M | Nov 25, 2020 |
| FY2019 | Sep 30, 2017 | $338.00M | Nov 22, 2019 |
| FY2018 | Sep 30, 2016 | $247.00M | Nov 21, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $59.00M | Nov 24, 2025 |
| FY2025 | Sep 30, 2024 | $63.00M | Nov 24, 2025 |
| FY2025 | Sep 30, 2023 | $57.00M | Nov 24, 2025 |
| FY2024 | Sep 30, 2022 | $55.00M | Nov 20, 2024 |
| FY2023 | Sep 30, 2021 | $56.00M | Nov 22, 2023 |
| FY2022 | Sep 30, 2020 | $57.00M | Nov 23, 2022 |
| FY2021 | Sep 30, 2019 | $60.00M | Nov 29, 2021 |
| FY2020 | Sep 30, 2018 | $66.00M | Nov 25, 2020 |
| FY2019 | Sep 30, 2017 | $57.00M | Nov 22, 2019 |
| FY2018 | Sep 30, 2016 | $53.00M | Nov 21, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $260.00M | Nov 24, 2025 |
| FY2025 | Sep 30, 2024 | $283.00M | Nov 24, 2025 |
| FY2025 | Sep 30, 2023 | $253.00M | Nov 24, 2025 |
| FY2024 | Sep 30, 2022 | $258.00M | Nov 20, 2024 |
| FY2023 | Sep 30, 2021 | $289.00M | Nov 22, 2023 |
| FY2022 | Sep 30, 2020 | $292.00M | Nov 23, 2022 |
| FY2021 | Sep 30, 2019 | $290.00M | Nov 29, 2021 |
| FY2020 | Sep 30, 2018 | $308.00M | Nov 25, 2020 |
| FY2019 | Sep 30, 2017 | $262.00M | Nov 22, 2019 |
| FY2018 | Sep 30, 2016 | $275.00M | Nov 21, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $665.00M | Nov 24, 2025 |
| FY2025 | Sep 30, 2024 | $692.00M | Nov 24, 2025 |
| FY2025 | Sep 30, 2023 | $595.00M | Nov 24, 2025 |
| FY2024 | Sep 30, 2022 | $100.00M | Nov 20, 2024 |
| FY2023 | Sep 30, 2021 | $257.00M | Nov 22, 2023 |
| FY2022 | Sep 30, 2020 | $377.00M | Nov 23, 2022 |
| FY2021 | Sep 30, 2019 | $363.00M | Nov 29, 2021 |
| FY2020 | Sep 30, 2018 | $298.00M | Nov 25, 2020 |
| FY2019 | Sep 30, 2017 | $348.00M | Nov 22, 2019 |
| FY2018 | Sep 30, 2016 | $392.00M | Nov 21, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $274.00M | Nov 24, 2025 |
| FY2025 | Sep 30, 2024 | $241.00M | Nov 24, 2025 |
| FY2025 | Sep 30, 2023 | $244.00M | Nov 24, 2025 |
| FY2024 | Sep 30, 2022 | $211.00M | Nov 20, 2024 |
| FY2023 | Sep 30, 2021 | $195.00M | Nov 22, 2023 |
| FY2022 | Sep 30, 2020 | $200.00M | Nov 23, 2022 |
| FY2021 | Sep 30, 2019 | $224.00M | Nov 29, 2021 |
| FY2020 | Sep 30, 2018 | $229.00M | Nov 25, 2020 |
| FY2019 | Sep 30, 2017 | $147.00M | Nov 22, 2019 |
| FY2018 | Sep 30, 2016 | $112.00M | Nov 21, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $3.82B | Nov 24, 2025 |
| FY2025 | Sep 30, 2024 | $3.74B | Nov 24, 2025 |
| FY2025 | Sep 30, 2023 | $3.60B | Nov 24, 2025 |
| FY2024 | Sep 30, 2022 | $3.53B | Nov 20, 2024 |
| FY2023 | Sep 30, 2021 | $3.31B | Nov 22, 2023 |
| FY2022 | Sep 30, 2020 | $2.78B | Nov 23, 2022 |
| FY2021 | Sep 30, 2019 | $3.00B | Nov 29, 2021 |
| FY2020 | Sep 30, 2018 | $3.24B | Nov 25, 2020 |
| FY2019 | Sep 30, 2017 | $3.34B | Nov 22, 2019 |
| FY2018 | Sep 30, 2016 | $3.05B | Nov 21, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $1.55B | Nov 24, 2025 |
| FY2025 | Sep 30, 2024 | $1.43B | Nov 24, 2025 |
| FY2024 | Sep 30, 2023 | $1.26B | Nov 20, 2024 |
| FY2023 | Sep 30, 2022 | $898.00M | Nov 22, 2023 |
| FY2022 | Sep 30, 2021 | $947.00M | Nov 23, 2022 |
| FY2021 | Sep 30, 2020 | $691.00M | Nov 29, 2021 |
| FY2020 | Sep 30, 2019 | $998.00M | Nov 25, 2020 |
| FY2019 | Sep 30, 2018 | $1.15B | Nov 22, 2019 |
| FY2018 | Sep 30, 2017 | $1.50B | Nov 21, 2018 |
| FY2017 | Sep 30, 2016 | $1.27B | Nov 22, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $134.00M | Nov 24, 2025 |
| FY2025 | Sep 30, 2024 | $133.00M | Nov 24, 2025 |
| FY2025 | Sep 30, 2023 | $134.00M | Nov 24, 2025 |
| FY2024 | Sep 30, 2022 | $129.00M | Nov 20, 2024 |
| FY2022 | Sep 30, 2021 | $140.00M | Nov 23, 2022 |
| FY2021 | Sep 30, 2020 | $134.00M | Nov 29, 2021 |
| FY2021 | Apr 1, 2020 | $45.00M | Nov 29, 2021 |
| FY2020 | Sep 30, 2019 | $90.00M | Nov 25, 2020 |
| FY2019 | Sep 30, 2018 | $93.00M | Nov 22, 2019 |
| FY2018 | Sep 30, 2017 | $154.00M | Nov 21, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $1.84B | Nov 24, 2025 |
| FY2025 | Sep 30, 2024 | $1.73B | Nov 24, 2025 |
| FY2024 | Sep 30, 2023 | $1.57B | Nov 20, 2024 |
| FY2023 | Sep 30, 2022 | $1.28B | Nov 22, 2023 |
| FY2022 | Sep 30, 2021 | $1.16B | Nov 23, 2022 |
| FY2021 | Sep 30, 2020 | $989.00M | Nov 29, 2021 |
| FY2020 | Sep 30, 2019 | $1.34B | Nov 25, 2020 |
| FY2019 | Sep 30, 2018 | $1.42B | Nov 22, 2019 |
| FY2018 | Sep 30, 2017 | $1.71B | Nov 21, 2018 |
| FY2017 | Sep 30, 2016 | $1.54B | Nov 22, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $258.00M | Nov 24, 2025 |
| FY2025 | Sep 30, 2024 | $223.00M | Nov 24, 2025 |
| FY2024 | Sep 30, 2023 | $238.00M | Nov 20, 2024 |
| FY2023 | Sep 30, 2022 | $206.00M | Nov 22, 2023 |
| FY2023 | Sep 30, 2021 | $168.00M | Nov 22, 2023 |
| FY2022 | Sep 30, 2020 | $151.00M | Nov 23, 2022 |
| FY2021 | Sep 30, 2019 | $169.00M | Nov 29, 2021 |
| FY2019 | Sep 30, 2018 | $175.00M | Nov 22, 2019 |
| FY2018 | Sep 30, 2017 | $280.00M | Nov 21, 2018 |
| FY2018 | Sep 30, 2016 | $200.00M | Nov 21, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $1.09B | Nov 24, 2025 |
| FY2024 | Sep 30, 2024 | $1.08B | Nov 20, 2024 |
| FY2023 | Sep 30, 2023 | $1.08B | Nov 22, 2023 |
| FY2022 | Sep 30, 2022 | $1.08B | Nov 23, 2022 |
| FY2021 | Sep 30, 2021 | $1.06B | Nov 29, 2021 |
| FY2020 | Sep 30, 2020 | $1.08B | Nov 25, 2020 |
| FY2019 | Sep 30, 2019 | $1.03B | Nov 22, 2019 |
| FY2018 | Sep 30, 2018 | $747.00M | Nov 21, 2018 |
| FY2017 | Sep 30, 2017 | $908.00M | Nov 22, 2017 |
| FY2016 | Sep 30, 2016 | $907.00M | Nov 23, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 6 | Nov 24, 2025 |
| FY2025 | Sep 30, 2024 | 6 | Nov 24, 2025 |
| FY2025 | Sep 30, 2023 | 7 | Nov 24, 2025 |
| FY2024 | Sep 30, 2022 | 3 | Nov 20, 2024 |
| FY2023 | Sep 30, 2021 | 4 | Nov 22, 2023 |
| FY2020 | Sep 30, 2020 | (4) | Nov 25, 2020 |
| FY2020 | Jun 30, 2020 | 0 | Nov 25, 2020 |
| FY2020 | Mar 31, 2020 | 0 | Nov 25, 2020 |
| FY2020 | Dec 31, 2019 | 0 | Nov 25, 2020 |
| FY2020 | Sep 30, 2019 | 0 | Nov 25, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 6 | Nov 24, 2025 |
| FY2025 | Sep 30, 2024 | 6 | Nov 24, 2025 |
| FY2025 | Sep 30, 2023 | 7 | Nov 24, 2025 |
| FY2024 | Sep 30, 2022 | 3 | Nov 20, 2024 |
| FY2023 | Sep 30, 2021 | 4 | Nov 22, 2023 |
| FY2020 | Sep 30, 2020 | (4) | Nov 25, 2020 |
| FY2020 | Jun 30, 2020 | 0 | Nov 25, 2020 |
| FY2020 | Mar 31, 2020 | 0 | Nov 25, 2020 |
| FY2020 | Dec 31, 2019 | 0 | Nov 25, 2020 |
| FY2020 | Sep 30, 2019 | 0 | Nov 25, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 52.84M | Nov 24, 2025 |
| FY2025 | Sep 30, 2024 | 54.30M | Nov 24, 2025 |
| FY2024 | Sep 30, 2023 | 55.24M | Nov 20, 2024 |
| FY2023 | Sep 30, 2022 | 56.25M | Nov 22, 2023 |
| FY2022 | Sep 30, 2021 | 56.73M | Nov 23, 2022 |
| FY2021 | Sep 30, 2020 | 56.47M | Nov 29, 2021 |
| FY2020 | Sep 30, 2019 | 57.08M | Nov 25, 2020 |
| FY2019 | Sep 30, 2018 | 60.37M | Nov 22, 2019 |
| FY2018 | Sep 30, 2017 | 61.88M | Nov 21, 2018 |
| FY2017 | Sep 30, 2016 | 62.21M | Nov 22, 2017 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $96.00M | Nov 24, 2025 |
| FY2025 | Sep 30, 2024 | $93.00M | Nov 24, 2025 |
| FY2025 | Sep 30, 2023 | $88.00M | Nov 24, 2025 |
| FY2024 | Sep 30, 2022 | $84.00M | Nov 20, 2024 |
| FY2023 | Sep 30, 2021 | $80.00M | Nov 22, 2023 |
| FY2022 | Sep 30, 2020 | $80.00M | Nov 23, 2022 |
| FY2021 | Sep 30, 2019 | $80.00M | Nov 29, 2021 |
| FY2020 | Sep 30, 2018 | $80.00M | Nov 25, 2020 |
| FY2019 | Sep 30, 2017 | $77.00M | Nov 22, 2019 |
| FY2018 | Sep 30, 2016 | $65.00M | Nov 21, 2018 |